FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37856911000001105: Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
510381000001112 Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
510391000001114 Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has AMP Nerlynx 40mg tablets (Pierre Fabre Ltd) true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Is a Neratinib 40mg tablets 180 tablet true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has specific active ingredient Neratinib maleate true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Neratinib true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start